Artelo Biosciences Inc. (NASDAQ:ARTL) does about 363.57K shares in volume on a normal day but saw 1839280 shares change hands in Friday trading. The company now has a market cap of 5.09M USD and an enterprise value of about $3.80M. Its current market price is $1.15, marking an increase of 1.77% compared to the previous close of $1.13. The 52 week high reached by this stock is $4.42 whilst the lowest price level in 52 weeks is $0.61. The script in recent trading has seen the stock touch a high of $1.21 and a low of $1.05.
Artelo Biosciences Inc. (ARTL) has a 20-day trading average at $1.1820 and the current price is -74.00% off the 52-week high compared with 88.52% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.2478 and its 200-day simple moving average is $1.5928. If we look at the stock’s price movements over the week, volatility stands at 12.76%, which decreases to 8.44% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 44.08 to suggest the stock is neutral.
1 analysts observing the Artelo Biosciences Inc. (ARTL) stock have set the 12-month price targets for the company’s shares at between $8.00 and $8.00. The median price target is 85.63% away from the current levels at $8.00.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
The current price level is -3.11%, -8.00%, and -28.07% away from its SMA20, SMA50, and SMA200 respectively, with the ARTL price moving above the 50-day SMA on August 14. Artelo Biosciences Inc. (ARTL) stock is down -7.99% over the week and -10.16% over the past month. Its price is -57.41% year-to-date and -59.74% over the past year.
The stock last released its quarterly earnings report for quarter ended 5/30/2020, with the company’s earnings per share (EPS) of -$0.27 above consensus estimates by $0.13. The company’s next earnings report is expected on 11/23/2020, with forecasts estimating quarterly EPS at -$0.36 and -$1.65 for whole year. ARTL’s earnings per share are forecast to shrink by -65.00% this year and 0.60% over next year.
Its 12-month price target is $8.00. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $8.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $8.00.
Outstanding shares total 3.47M with insiders holding 14.55% of the shares and institutional holders owning 0.23% of the company’s common stock. The company has a return on equity of -103.10%. Price to book ratio is 1.24.